Kwang-Ho Cha

Title: Kwang-Ho Cha: Innovator in Transdermal Drug Delivery Systems

Introduction

Kwang-Ho Cha is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of transdermal drug delivery systems. With a total of 2 patents, his work focuses on innovative solutions for treating dementia.

Latest Patents

Cha's latest patents include a percutaneous absorption preparation comprising stabilized donepezil. This preparation is designed for the treatment of dementia and features a support layer, a drug-containing layer, and a release layer. The drug-containing layer contains donepezil or a pharmaceutically acceptable salt as the active ingredient, along with stabilizers such as monothioglycerol and thiocyanate metal salt. Another patent involves a percutaneous absorption preparation that includes donepezil, propylene glycol monocaprylate as a solubilizer, and styrene-isoprene-styrene block copolymer as an adhesive. This formulation is noted for its low skin irritation and high skin penetration.

Career Highlights

Throughout his career, Kwang-Ho Cha has worked with prominent companies in the pharmaceutical industry, including Dong-a St Co., Ltd. and Km Transderm Ltd. His expertise in drug formulation and delivery systems has positioned him as a key player in the development of effective treatments for dementia.

Collaborations

Cha has collaborated with notable professionals in his field, including Sun-Woo Jang and Chang-Yell Shin. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Kwang-Ho Cha's contributions to the field of pharmaceutical technology, particularly in transdermal drug delivery systems, highlight his commitment to improving treatment options for dementia. His innovative patents and collaborations reflect his significant impact on the industry.